Related Experiment Video

Updated: Sep 3, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo

R L Paquette1, N Hsu, J Said

  • 1UCLA Department of Medicine, Division of Hematology/Oncology, Los Angeles, CA 90095-1678, USA.

Leukemia
|July 30, 2002
PubMed

Insights

Interferon-alpha (IFN-alpha) promotes dendritic cell (DC) differentiation in chronic myeloid leukemia (CML) patients. This IFN-alpha therapy may enhance anti-leukemia immunity by generating functional DCs, with impaired differentiation potentially causing treatment resistance.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the BCR-ABL fusion gene.
  • Dendritic cells (DCs) are crucial antigen-presenting cells in immune responses.
  • The role of DCs in CML pathogenesis and therapy remains incompletely understood.

Purpose of the Study:

  • To investigate the capacity of interferon-alpha (IFN-alpha) to induce dendritic cell (DC) differentiation in chronic myeloid leukemia (CML).
  • To assess the immunophenotype and function of DCs generated from CML progenitor cells.
  • To explore the relationship between DC differentiation and response to IFN-alpha therapy in CML.

Main Methods:

  • Culture of peripheral blood mononuclear cells from CML patients with IFN-alpha and granulocyte-macrophage colony-stimulating factor (GM-CSF).
  • Analysis of DC morphology, BCR-ABL translocation presence, and expression of HLA, CD40, CD54, CD80, and CD86.
  • Assessment of DC stimulatory capacity in allogeneic mixed leukocyte reactions.
  • Evaluation of bone marrow DC numbers in CML patients before and after IFN-alpha treatment.

Main Results:

  • IFN-alpha/GM-CSF induced differentiation of CML progenitor cells into DCs harboring the BCR-ABL translocation.
  • DCs generated with IFN-alpha/GM-CSF exhibited higher HLA class I and II expression compared to those cultured with IL-4/GM-CSF.
  • DCs from CML patients responding to IFN-alpha showed immunoregulatory protein expression comparable to normal DCs, while non-responders had reduced expression.
  • IFN-alpha responders showed increased bone marrow DC numbers with treatment, unlike non-responders.
  • DCs from IFN-alpha non-responders were less stimulatory in mixed leukocyte reactions.

Conclusions:

  • IFN-alpha effectively induces DC differentiation from CML progenitor cells both in vitro and in vivo.
  • The therapeutic efficacy of IFN-alpha in CML may be mediated by its ability to generate functional DCs capable of presenting leukemia-specific antigens.
  • Impaired DC differentiation in CML could be a mechanism of resistance to IFN-alpha therapy.

More Related Videos

In Vitro Generation of Murine Plasmacytoid Dendritic Cells from Common Lymphoid Progenitors using the AC-6 Feeder System08:18

In Vitro Generation of Murine Plasmacytoid Dendritic Cells from Common Lymphoid Progenitors using the AC-6 Feeder System

Published on: November 24, 2015

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...